190 related articles for article (PubMed ID: 29409832)
1. The tumor-suppressor cholesterol metabolite, dendrogenin A, is a new class of LXR modulator activating lethal autophagy in cancers.
Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2018 Jul; 153():75-81. PubMed ID: 29409832
[TBL] [Abstract][Full Text] [Related]
2. Dendrogenin A drives LXR to trigger lethal autophagy in cancers.
Segala G; David M; de Medina P; Poirot MC; Serhan N; Vergez F; Mougel A; Saland E; Carayon K; Leignadier J; Caron N; Voisin M; Cherier J; Ligat L; Lopez F; Noguer E; Rives A; Payré B; Saati TA; Lamaziere A; Despres G; Lobaccaro JM; Baron S; Demur C; de Toni F; Larrue C; Boutzen H; Thomas F; Sarry JE; Tosolini M; Picard D; Record M; Récher C; Poirot M; Silvente-Poirot S
Nat Commun; 2017 Dec; 8(1):1903. PubMed ID: 29199269
[TBL] [Abstract][Full Text] [Related]
3. From tamoxifen to dendrogenin A: The discovery of a mammalian tumor suppressor and cholesterol metabolite.
Silvente-Poirot S; de Medina P; Record M; Poirot M
Biochimie; 2016 Nov; 130():109-114. PubMed ID: 27262406
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent transcriptional induction of lethal autophagy: A new perspective for cancer treatment.
Silvente-Poirot S; Segala G; Poirot MC; Poirot M
Autophagy; 2018; 14(3):555-557. PubMed ID: 29368971
[TBL] [Abstract][Full Text] [Related]
5. Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties.
Dalenc F; Poirot M; Silvente-Poirot S
Curr Med Chem; 2015; 22(30):3533-49. PubMed ID: 26179999
[TBL] [Abstract][Full Text] [Related]
6. When cholesterol meets histamine, it gives rise to dendrogenin A: a tumour suppressor metabolite.
Poirot M; Silvente-Poirot S
Biochem Soc Trans; 2016 Apr; 44(2):631-7. PubMed ID: 27068981
[TBL] [Abstract][Full Text] [Related]
7. The cholesterol-derived metabolite dendrogenin A functionally reprograms breast adenocarcinoma and undifferentiated thyroid cancer cells.
Bauriaud-Mallet M; Vija-Racaru L; Brillouet S; Mallinger A; de Medina P; Rives A; Payre B; Poirot M; Courbon F; Silvente-Poirot S
J Steroid Biochem Mol Biol; 2019 Sep; 192():105390. PubMed ID: 31170473
[TBL] [Abstract][Full Text] [Related]
8. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties.
de Medina P; Paillasse MR; Segala G; Voisin M; Mhamdi L; Dalenc F; Lacroix-Triki M; Filleron T; Pont F; Saati TA; Morisseau C; Hammock BD; Silvente-Poirot S; Poirot M
Nat Commun; 2013; 4():1840. PubMed ID: 23673625
[TBL] [Abstract][Full Text] [Related]
9. Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.
Leignadier J; Dalenc F; Poirot M; Silvente-Poirot S
Biochem Pharmacol; 2017 Nov; 144():18-28. PubMed ID: 28642035
[TBL] [Abstract][Full Text] [Related]
10. A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues.
Soulès R; Audouard-Combe F; Huc-Claustre E; de Medina P; Rives A; Chatelut E; Dalenc F; Franchet C; Silvente-Poirot S; Poirot M; Allal B
J Steroid Biochem Mol Biol; 2019 Nov; 194():105447. PubMed ID: 31415823
[TBL] [Abstract][Full Text] [Related]
11. Targeting the liver X receptor with dendrogenin A differentiates tumour cells to secrete immunogenic exosome-enriched vesicles.
Record M; Attia M; Carayon K; Pucheu L; Bunay J; Soulès R; Ayadi S; Payré B; Perrin-Cocon L; Bourgailh F; Lamazière A; Lotteau V; Poirot M; Silvente-Poirot S; de Medina P
J Extracell Vesicles; 2022 Apr; 11(4):e12211. PubMed ID: 35411723
[TBL] [Abstract][Full Text] [Related]
12. Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite.
Poirot M; Soules R; Mallinger A; Dalenc F; Silvente-Poirot S
Biochimie; 2018 Oct; 153():139-149. PubMed ID: 29654865
[TBL] [Abstract][Full Text] [Related]
13. Dendrogenin A synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo.
Serhan N; Mouchel PL; Medina P; Segala G; Mougel A; Saland E; Rives A; Lamaziere A; Despres G; Sarry JE; Larrue C; Vergez F; Largeaud L; Record M; Récher C; Silvente-Poirot S; Poirot M
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610562
[TBL] [Abstract][Full Text] [Related]
14. Targeting NR1H/liver X receptor with dendrogenin A differentiates tumor cells to activate a new secretory pathway releasing immunogenic anti-tumor vesicles enriched in LC3-II-associated exosomes.
de Medina P; Bunay J; Poirot M; Record M; Silvente-Poirot S
Autophagy; 2023 Mar; 19(3):1036-1038. PubMed ID: 36063487
[TBL] [Abstract][Full Text] [Related]
15. Dendrogenin A Enhances Anti-Leukemic Effect of Anthracycline in Acute Myeloid Leukemia.
Mouchel PL; Serhan N; Betous R; Farge T; Saland E; De Medina P; Hoffmann JS; Sarry JE; Poirot M; Silvente-Poirot S; Récher C
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33053669
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of the tumor suppressor dendrogenin A using liquid chromatography tandem mass spectrometry.
Noguer E; Soules R; Netter C; Nagarathinam C; Leignadier J; Huc-Claustre E; Serhan N; Rives A; de Medina P; Silvente-Poirot S; Poirot M
Chem Phys Lipids; 2017 Oct; 207(Pt B):81-86. PubMed ID: 28684089
[TBL] [Abstract][Full Text] [Related]
17. Technical note: Hapten synthesis, antibody production and development of an enzyme-linked immunosorbent assay for detection of the natural steroidal alkaloid Dendrogenin A.
de Medina P; Paillasse MR; Segala G; Al Saati T; Boyes J; Delsol G; Allal C; Marsili S; Silvente-Poirot S; Poirot M
Biochimie; 2013 Mar; 95(3):482-8. PubMed ID: 22709869
[TBL] [Abstract][Full Text] [Related]
18. Improvement of 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, cholestane-3β,5α,6β-triol and 6-oxo-cholestan-3β,5α-diol recovery for quantification by GC/MS.
Soules R; Noguer E; Iuliano L; Zerbinati C; Leignadier J; Rives A; de Medina P; Silvente-Poirot S; Poirot M
Chem Phys Lipids; 2017 Oct; 207(Pt B):92-98. PubMed ID: 28554594
[TBL] [Abstract][Full Text] [Related]
19. One step synthesis of 6-oxo-cholestan-3β,5α-diol.
Voisin M; Silvente-Poirot S; Poirot M
Biochem Biophys Res Commun; 2014 Apr; 446(3):782-5. PubMed ID: 24508258
[TBL] [Abstract][Full Text] [Related]
20. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity.
Berrodin TJ; Shen Q; Quinet EM; Yudt MR; Freedman LP; Nagpal S
Mol Pharmacol; 2010 Dec; 78(6):1046-58. PubMed ID: 20837678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
